Related Articles
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
Superior mesenteric artery syndrome following esophageal cancer surgery: A report of two cases and a literature review
Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study
Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab‑paclitaxel chemotherapy: A case report